Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Catherine D. E. Wilder"'
Autor:
James Winter, Martin J. Bishop, Catherine D. E. Wilder, Christopher O'Shea, Davor Pavlovic, Michael J. Shattock
Publikováno v:
Frontiers in Physiology, Vol 9 (2018)
Rationale: Arrhythmogenic cardiac alternans are thought to be an important determinant for the initiation of ventricular fibrillation. There is limited information on the effects of sympathetic nerve stimulation (SNS) on alternans in the intact heart
Externí odkaz:
https://doaj.org/article/84c1a053dcf644699e8d8b5546ba4fab
Autor:
Catherine D. E. Wilder, Jade S. Munro, Michael J. Curtis, Nakita Ahdi, Georgia Lytra, Niraja N. Ranadive, Patrisia Qazimi, Louise M. Hesketh
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-11 (2020)
Scientific Reports
Hesketh, L M, Wilder, C D E, Ranadive, N N, Lytra, G, Qazimi, P, Munro, J S, Ahdi, N & Curtis, M J 2020, ' Characterisation of mexiletine’s translational therapeutic index for suppression of ischaemia-induced ventricular fibrillation in the rat isolated heart ', Scientific Reports, vol. 10, no. 1, 8397 . https://doi.org/10.1038/s41598-020-65190-y
Scientific Reports
Hesketh, L M, Wilder, C D E, Ranadive, N N, Lytra, G, Qazimi, P, Munro, J S, Ahdi, N & Curtis, M J 2020, ' Characterisation of mexiletine’s translational therapeutic index for suppression of ischaemia-induced ventricular fibrillation in the rat isolated heart ', Scientific Reports, vol. 10, no. 1, 8397 . https://doi.org/10.1038/s41598-020-65190-y
The ‘translational therapeutic index’ (TTI) is a drug’s ratio of nonclinical threshold dose (or concentration) for significant benefit versus threshold for adversity. In early nonclinical research, discovery and safety studies are normally unde
Autor:
Catherine D. E. Wilder, Ellice Caldwell-Dunn, Michael J. Curtis, Antonella Ranieri, Tutku Dursun, Hannah R. Lewis, Paul Gyimah, Nikoleta Pavlaki
Publikováno v:
British Journal of Pharmacology. 175:1669-1690
BACKGROUND & PURPOSE: Antiarrhythmic β-blockers are used in patients at risk of myocardial ischaemia, but the survival benefit and mechanisms are unclear. We hypothesised that β-blockers do not prevent ventricular fibrillation (VF), but instead inh
Autor:
Duygu Yazar, Thomas R. Eykyn, Radwa Masoud, Michael J. Curtis, Catherine D. E. Wilder, Brett A. O’Brien
Publikováno v:
British Journal of Pharmacology. 173:39-52
Background and purpose In drug research using the rat Langendorff heart preparation, it is possible to study left ventricular (LV) contractility using an intraventricular balloon (IVB), and arrhythmogenesis during coronary ligation-induced regional i
Autor:
Klaus-Dieter Schlüter, Soni Deshwal, Hans Erik Bøtker, Michael Rahbek-Schmidt, Derek J. Hausenloy, Zoltán Giricz, Péter Ferdinandy, Moises Di Sante, David Garcia-Dorado, Fabio Di Lisa, Kerstin Boengler, Nina Kaludercic, Pasquale Pagliaro, Marisol Ruiz-Meana, Andreas Skyschally, Sean M. Davidson, Borja Ibanez, Gerd Heusch, Michel Ovize, Ioanna Andreadou, Efstathios K. Iliodromitis, Catherine D. E. Wilder, Panagiotis Efentakis, Salvatore Antonucci, Markus Neuhäuser, Petra Kleinbongard, Rainer Schulz, Saveria Femminò, Derek M. Yellon, Yvan Devaux
Publikováno v:
Basic Research in Cardiology
Bøtker, H E, Hausenloy, D, Andreadou, I, Antonucci, S, Boengler, K, Davidson, S M, Deshwal, S, Devaux, Y, Di Lisa, F, Di Sante, M, Efentakis, P, Femminò, S, García-Dorado, D, Giricz, Z, Ibanez, B, Iliodromitis, E, Kaludercic, N, Kleinbongard, P, Neuhäuser, M, Ovize, M, Pagliaro, P, Rahbek-Schmidt, M, Ruiz-Meana, M, Schlüter, K-D, Schulz, R, Skyschally, A, Wilder, C, Yellon, D M, Ferdinandy, P & Heusch, G 2018, ' Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection ', Basic Research in Cardiology. Supplement, vol. 113, no. 5, pp. 39 . https://doi.org/10.1007/s00395-018-0696-8
Basic Research in Cardiology, Springer Verlag, 2018, 113 (5), pp.73
Repisalud
Instituto de Salud Carlos III (ISCIII)
Bøtker, H E, Hausenloy, D, Andreadou, I, Antonucci, S, Boengler, K, Davidson, S M, Deshwal, S, Devaux, Y, Di Lisa, F, Di Sante, M, Efentakis, P, Femminò, S, García-Dorado, D, Giricz, Z, Ibanez, B, Iliodromitis, E, Kaludercic, N, Kleinbongard, P, Neuhäuser, M, Ovize, M, Pagliaro, P, Rahbek-Schmidt, M, Ruiz-Meana, M, Schlüter, K-D, Schulz, R, Skyschally, A, Wilder, C, Yellon, D M, Ferdinandy, P & Heusch, G 2018, ' Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection ', Basic Research in Cardiology. Supplement, vol. 113, no. 5, pp. 39 . https://doi.org/10.1007/s00395-018-0696-8
Basic Research in Cardiology, Springer Verlag, 2018, 113 (5), pp.73
Repisalud
Instituto de Salud Carlos III (ISCIII)
The potential for ischemic preconditioning to reduce infarct size was first recognized more than 30 years ago. Despite extension of the concept to ischemic postconditioning and remote ischemic conditioning and literally thousands of experimental stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77a8943c1ccaa7e021aed8c824c38722
https://hal.archives-ouvertes.fr/hal-02003550
https://hal.archives-ouvertes.fr/hal-02003550
Autor:
Anna Starr, Christoph Thiemermann, Olena Rudyk, Claire A. Sand, Catherine D. E. Wilder, David F. Treacher, Domenico Spina, Manasi Nandi
Publikováno v:
Journal of Applied Physiology
Sepsis and sepsis-associated multiorgan failure represent the major cause of mortality in intensive care units worldwide. Cardiovascular dysfunction, a key component of sepsis pathogenesis, has received much research interest, although research trans
Autor:
Catherine D E, Wilder, Nikoleta, Pavlaki, Tutku, Dursun, Paul, Gyimah, Ellice, Caldwell-Dunn, Antonella, Ranieri, Hannah R, Lewis, Michael J, Curtis
Publikováno v:
British journal of pharmacology. 175(10)
BACKGROUND AND PURPOSE: Antiarrhythmic β‐blockers are used in patients at risk of myocardial ischaemia, but the survival benefit and mechanisms are unclear. We hypothesized that β‐blockers do not prevent ventricular fibrillation (VF) but instea
Autor:
James, Winter, Martin J, Bishop, Catherine D E, Wilder, Christopher, O'Shea, Davor, Pavlovic, Michael J, Shattock
Publikováno v:
Frontiers in Physiology
Rationale: Arrhythmogenic cardiac alternans are thought to be an important determinant for the initiation of ventricular fibrillation. There is limited information on the effects of sympathetic nerve stimulation (SNS) on alternans in the intact heart
Autor:
Catherine D E, Wilder, Radwa, Masoud, Duygu, Yazar, Brett A, O'Brien, Thomas R, Eykyn, Michael J, Curtis
Publikováno v:
British journal of pharmacology. 173(1)
In drug research using the rat Langendorff heart preparation, it is possible to study left ventricular (LV) contractility using an intraventricular balloon (IVB), and arrhythmogenesis during coronary ligation-induced regional ischaemia. Assessing bot
Autor:
Hesketh, Louise M.1 (AUTHOR), Sikkel, Markus B.2 (AUTHOR), Mahoney‐Sanchez, Laura1 (AUTHOR), Mazzacuva, Francesca3 (AUTHOR), Chowdhury, Rasheda A.2 (AUTHOR), Tzortzis, Konstantinos N.2 (AUTHOR), Firth, Jahn2 (AUTHOR), Winter, James1 (AUTHOR), MacLeod, Kenneth T.2 (AUTHOR), Ogrodzinski, Stefan4 (AUTHOR), Wilder, Catherine D. E.1 (AUTHOR), Patterson, Laurence H.4 (AUTHOR), Peters, Nicholas S.2 (AUTHOR), Curtis, Michael J.1 (AUTHOR) michael.curtis@kcl.ac.uk
Publikováno v:
British Journal of Pharmacology. May2022, Vol. 179 Issue 9, p2037-2053. 17p. 1 Diagram, 6 Graphs.